Irvin Mayers


Professor, Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta

Dr. Mayers’ clinical interests include asthma, chronic obstructive pulmonary disease (COPD) and sleep medicine.

His research interests include the translation of clinical research to clinical practice, including health technology assessment.

Dr. Mayers is an active collaborator within the University of Alberta Pulmonary Research Group and is evaluating the role of nuclear magnetic resonance (NMR) spectroscopy to better define metabolic pathways and improve the understanding of phenotypic variability in asthma.

Regionally, he is the Alberta Health Services Medicine site chief for the University of Alberta Hospitals. Provincially, Dr. Mayers is the Medical Advisor to Respiratory Benefits Program. Nationally, he is chair of the Health Canada Scientific Advisory Committee- Respiratory Allergy Therapeutics.

He was previously divisional director of Pulmonary Medicine (2001-2011), and president of the Canadian Thoracic Society (CTS).

All CIC publications featuring Dr. Mayers as a co-author are listed below.

Total Records Found: 3, showing 100 per page
Gauvreau GM, Boulet LP, Leigh R, Cockcroft DW, Davis BE, Mayers I et al. 2016

Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses

Journal of Allergy and Clinical Immunology

Gauvreau GM, Harris JM, Boulet LP, Sheerens H, FitzGerald JM, Putnam WS, Cockcroft DW, Davis BE, Leigh R, Zheng Y, Dahlén B, Wang Y, Maciuca R, Mayers I, Liao XC, Wu LC, Matthews JG, O'Byrne PM. 2014

Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production

Science Translational Medicine

Gauvreau GM, Boulet L-P, Cockcroft DW, FitzGerald JM, Mayers I, Carlsten C, Laviolette M, Killian KJ, Davis BE, Larché M , Kipling C , Dua B , Mosesova S , Putnam W , Zheng Y, Scheerens H, McClintock D , Matthews J, O'Byrne PM 2014

OX40L blockade on allergen-induced airway responses in subjects with mild asthma

Clinical Experimental Allergy

WordPress Image Lightbox